1,3,5-Trimethyl-6-nitro-1,3-dihydro-2H-benzo[d]imidazol-2-one

Catalog No. :
ACMVEU853
CAS No. :
1092013-22-3
Molecular Formula :
C10H11N3O3
Molecular Weight :
221.22

IUPAC Name:1,3,5-trimethyl-6-nitro-1,3-dihydro-2H-benzo[d]imidazol-2-one

1,3,5-Trimethyl-6-nitro-1,3-dihydro-2H-benzo[d]imidazol-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$57.00Login to see priceIn stockInquiry
1g97%$153.00Login to see priceIn stockInquiry
5g97%$532.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3,5-Trimethyl-6-nitro-1,3-dihydro-2H-benzo[d]imidazol-2-one
IUPAC Name1,3,5-trimethyl-6-nitro-1,3-dihydro-2H-benzo[d]imidazol-2-one
Molecular FormulaC10H11N3O3
Molecular Weight221.22
SMILESO=C1N(C)C2=CC(C)=C([N+]([O-])=O)C=C2N1C
InChI KeyOMPYKGLOVBKBOF-UHFFFAOYSA-N
Synonym1,3,5-Trimethyl-6-nitro-1,3-dihydro-benzoimidazol-2-one;2H-Benzimidazol-2-one, 1,3-dihydro-1,3,5-trimethyl-6-nitro-;1,3,5-Trimethyl-6-nitro-1,3-dihydro-2H-benzo[ d]imidazol-2-one
CAS No.1092013-22-3
PubChem CID27042813

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACMVEU853 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMVEU853 route product structure diagram
    ACMVEU8531092013-22-3 In Stock
Inquiry

2. ACMVEU853 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMVEU853 route product structure diagram
    ACMVEU8531092013-22-3 In Stock
Inquiry

Comments (0)